- Home
- THTX vs VTN Comparison
THTX vs VTN Comparison
Compare THTX & VTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- VTN
- Stock Information
- Founded
- THTX 1993
- VTN 1992
- Country
- THTX Canada
- VTN United States
- Employees
- THTX N/A
- VTN N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- VTN Finance Companies
- Sector
- THTX Health Care
- VTN Finance
- Exchange
- THTX Nasdaq
- VTN Nasdaq
- Market Cap
- THTX 144.8M
- VTN 151.5M
- IPO Year
- THTX N/A
- VTN N/A
- Fundamental
- Price
- THTX $3.29
- VTN $10.81
- Analyst Decision
- THTX Hold
- VTN
- Analyst Count
- THTX 1
- VTN 0
- Target Price
- THTX N/A
- VTN N/A
- AVG Volume (30 Days)
- THTX 372.3K
- VTN 41.7K
- Earning Date
- THTX 10-09-2025
- VTN 01-01-0001
- Dividend Yield
- THTX N/A
- VTN 3.74%
- EPS Growth
- THTX N/A
- VTN N/A
- EPS
- THTX N/A
- VTN 0.16
- Revenue
- THTX $84,378,000.00
- VTN N/A
- Revenue This Year
- THTX N/A
- VTN N/A
- Revenue Next Year
- THTX $13.76
- VTN N/A
- P/E Ratio
- THTX N/A
- VTN $67.06
- Revenue Growth
- THTX 2.19
- VTN N/A
- 52 Week Low
- THTX $1.12
- VTN $8.49
- 52 Week High
- THTX $3.31
- VTN $10.81
- Technical
- Relative Strength Index (RSI)
- THTX 70.36
- VTN 78.12
- Support Level
- THTX $3.26
- VTN $10.08
- Resistance Level
- THTX $3.31
- VTN $10.88
- Average True Range (ATR)
- THTX 0.02
- VTN 0.11
- MACD
- THTX -0.00
- VTN 0.07
- Stochastic Oscillator
- THTX 71.43
- VTN 91.48
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About VTN Invesco Trust for Investment Grade New York Municipals
Invesco Trust For Investment Grade New York Municipals is a diversified closed-end management investment company. Its objective is to provide common shareholders with a high level of current income exempt from federal as well as from New York State and New York City income taxes, consistent with preservation of capital.